Viral hepatitis and injection drug use in Appalachian Kentucky: A survey of rural health department clients

Public Health Reports

Volumn 125, Issue 1, 2010, Pages 121-128

  Christian, W Jay ^a   Hopenhayn, Claudia ^a,b   Christian, A M Y ^a   McIntosh, Deana ^c   Koch, Alvaro ^d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^c Kentucky River District Health Department   (United States)

^d UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG USE; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; POVERTY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; RURAL HEALTH CARE; SCREENING TEST; UNITED STATES; VIRUS TRANSMISSION;

EID: 74849109694     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335491012500116     Document Type: Article

References (25)

1. Fuller CM, Ompad DC, Galea S, Wu Y, Koblin B, Vlahov D. Hepatitis C incidence - a comparison between injection and noninjection drug users in New York City. J Urban Health 2004;81:20-4.
2. Miller CL, Wood E, Spittal PM, Li K, Frankish JC, Braitstein P, et al. The future face of co-infection: prevalence and incidence of HIV and hepatitis C virus co-infection among young injection drug users. J Acquir Immune Defic Syndr 2004;36:743-9.
3. Des Jarlais DC, Diaz T, Perlis T, Vlahov D, Maslow C, Latka M, et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol 2003;157:467-71.
4. Weissenbacher M, Rossi D, Radulich G, Sosa-Estani S, Vila M, Vivas E, et al. High seroprevalence of bloodborne viruses among street-recruited injection drug users from Buenos Aires, Argentina. Clin Infect Dis 2003;37 Suppl 5:S348-52.
5. Kentucky Department for Public Health. Reportable diseases in Kentucky, 2003 summary. Frankfort (KY): Kentucky Department for Public Health, Division of Epidemiology and Health Planning; 2004.
6. Summary of notifiable diseases - United States, 2003 [published erratum appears in MMWR Morb Mortal Wkly Rep 2006;55(28):779]. MMWR Morb Mortal Wkly Rep 2005;52(54):1-85.
7. Census Bureau (US). Census 2000 [cited 2008 Jun 26]. Available from: URL: http://www.census.gov 8. Pollard KM. Appalachia at the millennium: an overview of the results from Census 2000. Washington: Population Reference Bureau; 2003.
8. StataCorp. Stata® : Release 10.0. College Station (TX): StataCorp.; 2007.
9. Office of Employment and Training. Workforce Kentucky [cited 2009 Apr 27]. Available from: URL: http://www.workforcekentucky. ky.gov
10. Weightman R, Walton R, Bury J. Audit of bloodborne virus prevention activity with drug users seen in primary care. Commun Dis Public Health 2004;7:301-5.
11. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705-14.
12. Monnet E, Collin-Naudet E, Bresson-Hadni S, Minello A, Di Martino V, Carel D, et al. Place of residence and distance to medical care influence the diagnosis of hepatitis C: a population-based study. J Hepatol 2006;44:499-506.
13. Vogt TM, Perz JF, Van Houten CK Jr, Harrington R, Hansuld T, Bialek SR, et al. An outbreak of hepatitis B virus infection among methamphetamine injectors: the role of sharing injection drug equipment. Addiction 2006;101:726-30.
14. Stratton E, Sweet L, Latorraca-Walsh A, Gully PR. Hepatitis C in Prince Edward Island: a descriptive review of reported cases, 1990-1995. Can J Public Health 1997;88:91-4.
15. Poulin C, Gyorkos T, Joseph L, Schlech W III, Lee S. An epidemic of hepatitis B among injection drug users in a rural area. Can J Public Health 1992;83:102-5.
16. Havens JR, Walker R, Leukefeld CG. Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users. Drug Alcohol Depend 2007;87:98-102.
17. Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology 2002;36(5 Suppl 1):S99-105.
18. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26(3 Suppl 1):S62-5.
19. Neumayr G, Propst A, Schwaighofer H, Judmaier G, Vogel W. Lack of evidence for the heterosexual transmission of hepatitis C. QJM 1999;92:505-8.
20. Centers for Disease Control and Prevention (US). HIV/AIDS surveillance report, 2005, volume 17, revised edition. Atlanta: Department of Health and Human Services, CDC (US); 2007.
21. Census Bureau (US). Small area income and poverty estimates [cited 2009 Jan 16]. Available from: URL: http://www.census.gov/ did/www/saipe/index.html
22. Lima MP, Pedro RJ, Rocha MD. Prevalence and risk factors for hepatitis C virus (HCV) infection among pregnant Brazilian women. Int J Gynaecol Obstet 2000;70:319-26.
23. Zhang Z, Infante A, Meit M, English N, Dunn M, Bowers K, editors. An analysis of mental health and substance abuse disparities & access to treatment services in the Appalachian region: final report. Washington: Appalachian Regional Commission; 2008.
24. Hoffman HL, Castro-Donlan CA, Johnson VM, Church DR. The Massachusetts HIV, hepatitis, addiction services integration (HHASI) experience: responding to the comprehensive needs of individuals with co-occurring risks and conditions. Public Health Rep 2004;119:25-31.
25. Buffington J, Jones TS. Integrating viral hepatitis prevention into public health programs serving people at high risk for infection: good public health. Public Health Rep 2007;122 Suppl 2:S1-5.